MEDISCA Australia | Fundamental Principles and Practices for Personalized Bioidentical Hormone Restoration Therapy Webinar Series | June 2022
Personalizing hormone therapy with compounded treatments considers the interplay between hormones and other systems involved in hormonal health and wellness as well as patients’ needs and preferences.
This 5-part webinar series explores the fundamental principles and practices to consider for personalizing hormone therapies for various conditions with underlying hormone imbalances such as menopause, adrenal hypofunction, and hypothyroidism. Each webinar reviews a hormonal condition in the context of its physiology and associated therapies, including compounded treatment opportunities supported by evidence-based clinical data and case-based assessments to give you and your practice maximum advantage in patient-tailored care.
The course material is copyright © 2012-2022 LP3 Network.
Physicians, pharmacists and general practitioners engaged in prescription hormone practice.
Please note that the live stream will take place at 8pm PHT (Philippines Time)
Part I: Evaluating the Risks (Perimenopause and Menopause HRT)
A detailed look at the menstrual cycle, with a focus on specific hormone imbalances and associated symptoms, and treatment options available to restore hormone balance, including compounded estrogen and progesterone as hormone restoration therapy.
Monday, June 6:
Part II: Patient Evaluation and Treatment Protocols
A deep dive into patient symptom assessment charts, pros and cons of different hormone testing options, a review of treatment protocols for perimenopause, menopause, and vaginal atrophy, and discussions on selecting a route of delivery for compounding hormone restoration therapy.
Friday, June 10:
Part III: DHEA and Testosterone
An overview of androgen physiology in women, including the roles that both DHEA and testosterone play and rationale to support their use as androgen replacement therapy for hormone restoration in menopause and androgen insufficiency.
Monday, June 13:
Part IV: Adrenal Hypofunction
A review of the different hormones and stages of the stress response, focusing on the diagnosis of adrenal hypofunction and its treatment with current compounded treatment protocols.
Monday, June 20:
Part V: Hypothyroidism
An overview of thyroid hormone physiology and their role in thyroid dysfunction, with a review on current hypothyroid treatments and compounding opportunities, such as the exclusion of unwanted ingredients and combination therapies.
Thursday, June 23:
|TARA D. SCOTT, MD, FACOG, FAAFM, ABOIM, NCMP
Facilitator, LP3 Network; Fellow of American College of OB/GYN; Advanced Fellow and certified in Anti-aging, Regenerative, and Functional Medicine; Board Certified, American Board of Integrative Medicine, Certified Menopause Practitioner, North American Menopause Society; Clinical Associate Professor of OB/GYN, Northeast Ohio Medical University; Chief Medical Officer, Revitalize Medical Group; Medical Director of Integrative Medicine, Summa Health Systems
Dr. Tara Scott graduated from Northeast Ohio University College of Medicine and completed her residency with Summa Health Systems at Akron City Hospital in Ohio. She recently retired from OB/GYN after almost 20 years to focus on functional and integrative medicine. She is a Clinical Associate Professor at Northeast Ohio Medical University, where she teaches residents and is involved in clinical research.
Dr. Scott is a certified menopause practitioner with the North American Menopause Society and a fellow of the American College of Obstetrics and Gynecology. She first became involved with hormone and integrative medicine while practicing as an OB/GYN. Her empathy for patients experiencing hormone-related issues led her to become trained as an advanced fellow and certified by the American Academy of Anti-Aging Medicine. The evidence-based practices she employed helped many patients conquer chronic wellness issues. She then started Revitalize Medical Group, where she serves as the Chief Medical Officer. In 2016, she obtained an additional board certification in Integrative Medicine. Recently, Dr. Scott was appointed as Medical Director for Summa Health in Akron, Ohio, where she will develop and run an Integrative Medicine program. Dr. Scott is passionate about educating the medical community on the advances in evidence-based hormone therapy. She lectures around the community to raise awareness about wellness and hormone balance.
CANCELLATION AND REFUND POLICY
In the event that MEDISCA Australia cancels a course, MEDISCA Australia’s sole liability shall be course repayment. In no event shall MEDISCA Australia be responsible for any costs arising from such cancellation, including but not limited to travel and/or accommodation.In the event a Registrant cancels their enrollment in a CPD Activity, a written request must be sent to MEDISCA Australia requesting ‘Cancellation without Transfer’ to an alternate live CPD Activity event date. If cancellation occurs at greater than or equal to 31 days from live activity event date, then registrant will receive a 75% refund; 15-30 days a 50% refund; and less than or equal to 14 days no refund. MEDISCA Australia shall be excused from any delay caused by reason of any occurrence or contingency beyond its reasonable control (a “Force Majeure”), including but not limited to, acts of God, hurricane, earthquake, labour disputes, strikes, riots, war, and governmental requirements. The obligation to pay money to MEDISCA Australia in a timely manner is absolute and shall not be subject to this Force Majeure provision. In such event, MEDISCA Australia will not issue any refunds, only transfer to an alternate live activity event date.This cancellation and refund policy is specific to courses offered in Australia. To obtain information on the cancellation and refund policy for courses offered outside of Australia, please speak to a MEDISCA Australia representative or refer to your course-specific registration page.
TRANSFER POLICY - AUSTRALIA COURSES ONLY
This transfer policy is only applicable to courses that are offered in Australia. Transfer policy is only in effect if requested greater than or equal to 14 days prior to the original live activity event date. Failure to submit “Transfer Request” at least 14 days prior to original live activity event date will default to “Cancellation and Refund Policy”. Transfer policy can only apply one (1) time. Transfer to a new live event date must be within current calendar year. Failure to attend the new live activity event will lead to no refund and will no longer be transferable. Confirmation of new activity date is subject to the approval by MEDISCA Australia based on the number of available seats within the selected live activity event.